{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:13:26Z","timestamp":1783710806849,"version":"3.55.0"},"reference-count":35,"publisher":"Xia & He Publishing","issue":"X","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,28]]},"DOI":"10.14218\/jcth.2019.00038","type":"journal-article","created":{"date-parts":[[2020,2,2]],"date-time":"2020-02-02T21:00:46Z","timestamp":1580677246000},"page":"1-4","source":"Crossref","is-referenced-by-count":0,"title":["The Reliability of Fibro-test in Staging Orthotopic Liver Transplant Recipients with Recurrent Hepatitis C"],"prefix":"10.14218","volume":"X","author":[{"given":"Panagiotis","family":"Trilianos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adamantios","family":"Tsangaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustine","family":"Tawadros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vrushak","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Pyrsopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","published-online":{"date-parts":[[2020,2,2]]},"reference":[{"key":"key20200202210043_b1","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1053\/jlts.2003.50248","article-title":"The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients","volume":"9","author":"Gane","year":"2003","journal-title":"Liver Transpl"},{"key":"key20200202210043_b2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2002.32418","article-title":"The association between hepatitis C infection and survival after orthotopic liver transplantation","volume":"122","author":"Forman","year":"2002","journal-title":"Gastroenterology"},{"key":"key20200202210043_b3","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1053\/jhep.2000.17924","article-title":"Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation","volume":"32","author":"Berenguer","year":"2000","journal-title":"Hepatology"},{"key":"key20200202210043_b4","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/lt.25424","article-title":"Improved graft survival after liver transplantation for recipients with hepatitis C virus in the direct-acting antiviral era","volume":"25","author":"Cotter","year":"2019","journal-title":"Liver Transpl"},{"key":"key20200202210043_b5","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2018.06.010","article-title":"Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry","volume":"69","author":"Belli","year":"2018","journal-title":"J Hepatol"},{"key":"key20200202210043_b6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.14218\/JCTH.2016.00001","article-title":"Curing hepatitis C in liver transplant recipients is associated with changes in immunosuppressant use","volume":"4","author":"Saab","year":"2016","journal-title":"J Clin Transl Hepatol"},{"key":"key20200202210043_b7","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1053\/jhep.2003.09022","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C","volume":"38","author":"Bedossa","year":"2003","journal-title":"Hepatology"},{"key":"key20200202210043_b8","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1373\/clinchem.2004.032227","article-title":"Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C","volume":"50","author":"Poynard","year":"2004","journal-title":"Clin Chem"},{"key":"key20200202210043_b9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0168-8278(86)80075-7","article-title":"Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies","volume":"2","author":"Piccinino","year":"1986","journal-title":"J Hepatol"},{"key":"key20200202210043_b10","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cgh.2010.03.025","article-title":"Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial","volume":"8","author":"Seeff","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20200202210043_b11","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/lt.21781","article-title":"Late protocol liver biopsies in the liver allograft: a neglected investigation?","volume":"15","author":"Mells","year":"2009","journal-title":"Liver Transpl"},{"key":"key20200202210043_b12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-230X-7-40","article-title":"Meta-analyses of FibroTest diagnostic value in chronic liver disease","volume":"7","author":"Poynard","year":"2007","journal-title":"BMC Gastroenterol"},{"key":"key20200202210043_b13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jhep.2012.04.025","article-title":"Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population","volume":"57","author":"Poynard","year":"2012","journal-title":"J Hepatol"},{"key":"key20200202210043_b14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.gcb.2010.05.001","article-title":"ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure","volume":"34","author":"Poynard","year":"2010","journal-title":"Gastroenterol Clin Biol"},{"key":"key20200202210043_b15","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1111\/ajt.14895","article-title":"The impact of direct-acting antiviral agents on liver and kidney transplant costs and outcomes","volume":"18","author":"Axelrod","year":"2018","journal-title":"Am J Transplant"},{"key":"key20200202210043_b16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2015.05.010","article-title":"Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease","volume":"149","author":"Charlton","year":"2015","journal-title":"Gastroenterology"},{"key":"key20200202210043_b17","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.29258","article-title":"Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET study","volume":"66","author":"Saxena","year":"2017","journal-title":"Hepatology"},{"key":"key20200202210043_b18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jhep.2016.05.039","article-title":"Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study","volume":"65","author":"Coilly","year":"2016","journal-title":"J Hepatol"},{"key":"key20200202210043_b19","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/hep.30046","article-title":"Glecaprevir\/pibrentasvir treatment in liver or kidney transplant patients with hepatitis C virus infection","volume":"68","author":"Reau","year":"2018","journal-title":"Hepatology"},{"key":"key20200202210043_b20","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/hep.28446","article-title":"Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence","volume":"63","author":"Poordad","year":"2016","journal-title":"Hepatology"},{"key":"key20200202210043_b21","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s40262-019-00774-0","article-title":"Viral hepatitis C therapy: Pharmacokinetic and pharmacodynamic considerations: A 2019 update","volume":"58","author":"Smolders","year":"2019","journal-title":"Clin Pharmacokinet"},{"key":"key20200202210043_b22","doi-asserted-by":"crossref","first-page":"807","DOI":"10.7326\/0003-4819-158-11-201306040-00005","article-title":"Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review","volume":"158","author":"Chou","year":"2013","journal-title":"Ann Intern Med"},{"key":"key20200202210043_b23","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1478-3231.2009.02192.x","article-title":"Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients","volume":"30","author":"Kim","year":"2010","journal-title":"Liver Int"},{"key":"key20200202210043_b24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-5926-3-8","article-title":"Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C","volume":"3","author":"Poynard","year":"2004","journal-title":"Comp Hepatol"},{"key":"key20200202210043_b25","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/apt.13770","article-title":"Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference","volume":"44","author":"Munteanu","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"key20200202210043_b26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jhep.2011.05.024","article-title":"Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study","volume":"56","author":"Zarski","year":"2012","journal-title":"J Hepatol"},{"key":"key20200202210043_b27","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/TP.0b013e3181cc66ca","article-title":"Assessment of allograft fibrosis by transient elastography and noninvasive biomarker scoring systems in liver transplant patients","volume":"89","author":"Beckebaum","year":"2010","journal-title":"Transplantation"},{"key":"key20200202210043_b28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.dld.2008.06.009","article-title":"Assessment of liver fibrosis in transplant recipients with recurrent HCV infection: usefulness of transient elastography","volume":"41","author":"Corradi","year":"2009","journal-title":"Dig Liver Dis"},{"key":"key20200202210043_b29","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1432-2277.2009.00834.x","article-title":"Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis","volume":"22","author":"Alric","year":"2009","journal-title":"Transpl Int"},{"key":"key20200202210043_b30","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1432-2277.2010.01142.x","article-title":"Noninvasive tests for evaluation of fibrosis in HCV recurrence after liver transplantation: a systematic review","volume":"23","author":"Cholongitas","year":"2010","journal-title":"Transpl Int"},{"key":"key20200202210043_b31","first-page":"200","article-title":"Usefulness of acoustic radiation force impulse and fibrotest in liver fibrosis assessment after liver transplant","volume":"15","author":"Bignulin","year":"2016","journal-title":"Ann Hepatol"},{"key":"key20200202210043_b32","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/TP.0b013e31826e592e","article-title":"Calcineurin inhibition and new-onset diabetes mellitus after transplantation","volume":"95","author":"Chakkera","year":"2013","journal-title":"Transplantation"},{"key":"key20200202210043_b33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/cpt.546","article-title":"Calcineurin inhibitors: Pharmacologic mechanisms impacting both insulin resistance and insulin secretion leading to glucose dysregulation and diabetes mellitus","volume":"101","author":"Chakkera","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"key20200202210043_b34","doi-asserted-by":"crossref","first-page":"e0185192","DOI":"10.1371\/journal.pone.0185192","article-title":"Performance of transient elastography and serum fibrosis biomarkers for non-invasive evaluation of recurrent fibrosis after liver transplantation: A meta-analysis","volume":"12","author":"Bhat","year":"2017","journal-title":"PLoS One"},{"key":"key20200202210043_b35","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/lt.20857","article-title":"Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation","volume":"12","author":"Carri\u00f3n","year":"2006","journal-title":"Liver Transpl"}],"container-title":["Journal of Clinical and Translational Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.xiahepublishing.com\/2310-8819\/ArticleFullText.aspx?sid=2&id=10.14218%2fJCTH.2019.00038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:17:47Z","timestamp":1783707467000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.xiahepublishing.com\/2310-8819\/ArticleFullText.aspx?sid=2&id=10.14218%2fJCTH.2019.00038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,2]]},"references-count":35,"journal-issue":{"issue":"X","published-online":{"date-parts":[[2020,2,2]]},"published-print":{"date-parts":[[2020,3,28]]}},"alternative-id":["10.14218\/JCTH.2019.00038"],"URL":"https:\/\/doi.org\/10.14218\/jcth.2019.00038","relation":{},"ISSN":["2225-0719","2310-8819"],"issn-type":[{"value":"2225-0719","type":"print"},{"value":"2310-8819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,2]]}}}